Differential effects of m1 and m2 receptor antagonists in perirhinal cortex on visual recognition memory in monkeys

Neurobiology of Learning and Memory

Volumn 98, Issue 1, 2012, Pages 41-46

  Wu, Wei ^a   Saunders, Richard C ^a   Mishkin, Mortimer ^a   Turchi, Janita ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Cholinergic; Methoctramine; Muscarinic; Perirhinal cortex; Pirenzepine

Indexed keywords

METHOCTRAMINE; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; PIRENZEPINE; SCOPOLAMINE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; HAPLORHINI; INSULA; LATENT PERIOD; MALE; NONHUMAN; PERIRHINAL CORTEX; SIGNAL TRANSDUCTION; SPATIAL MEMORY; VISUAL MEMORY; VISUAL STIMULATION;

ANIMALS; CEREBRAL CORTEX; DIAMINES; MACACA MULATTA; MALE; MUSCARINIC ANTAGONISTS; PIRENZEPINE; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECOGNITION (PSYCHOLOGY); SCOPOLAMINE HYDROBROMIDE;

EID: 84863100951     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2012.04.007     Document Type: Article

References (53)

1. Aigner T.G., Mishkin M. The effects of physostigmine and scopolamine on recognition memory in monkeys. Behavioral and Neural Biology 1986, 45(1):81-87.
2. Aigner T.G., Walker D.L., Mishkin M. Comparison of the effects of scopolamine administered before and after acquisition in a test of visual recognition memory in monkeys. Behavioral and Neural Biology 1991, 55(1):61-67.
3. Alcantara A.A., Mrzljak L., Jakab R.L., Levey A.I., Hersch S.M., Goldman-Rakic P.S. Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: anatomical evidence for cholinergic modulation of glutamatergic prefronto-striatal pathways. Journal of Comparative Neurology 2001, 434(4):445-460.
4. Allen T.G., Brown D.A. M2 muscarinic receptor-mediated inhibition of the Ca2+ current in rat magnocellular cholinergic basal forebrain neurones. Journal of Physiology 1993, 466:173-189.
5. Birdsall N.J., Curtis C.A., Eveleigh P., Hulme E.C., Pedder E.K., Poyner D., et al. Muscarinic receptor subtypes and the selectivity of agonists and antagonists. Pharmacology 1988, 37(Suppl. 1):22-31.
6. Bonner T.I. The molecular basis of muscarinic receptor diversity. Trends in Neurosciences 1989, 12(4):148-151.
7. Buckley N.J., Bonner T.I., Buckley C.M., Brann M.R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Molecular Pharmacology 1989, 35(4):469-476.
8. Calabresi P., Centonze D., Gubellini P., Pisani A., Bernardi G. Endogenous ACh enhances striatal NMDA-responses via m1-like muscarinic receptors and PKC activation. European Journal of Neuroscience 1998, 10(9):2887-2895.
9. Caulfield M.P. Muscarinic receptors-characterization, coupling and function. Pharmacology & Therapeutics 1993, 58(3):319-379.
10. Cho K., Kemp N., Noel J., Aggleton J.P., Brown M.W., Bashir Z.I. A new form of long-term depression in the perirhinal cortex. Nature Neuroscience 2000, 3(2):150-156. 10.1038/72093.
11. Dorje F., Wess J., Lambrecht G., Tacke R., Mutschler E., Brann M.R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. Journal of Pharmacology and Experimental Therapeutics 1991, 256(2):727-733.
12. Eglen R.M. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Autonomic & Autacoid Pharmacology 2006, 26(3):219-233. 10.1111/j.1474-8673.2006.00368.x.
13. Egorov A.V., Hamam B.N., Fransen E., Hasselmo M.E., Alonso A.A. Graded persistent activity in entorhinal cortex neurons. Nature 2002, 420(6912):173-178. 10.1038/nature01171 nature01171.
14. Fahy F.L., Riches I.P., Brown M.W. Neuronal activity related to visual recognition memory: Long-term memory and the encoding of recency and familiarity information in the primate anterior and medial inferior temporal and rhinal cortex. Experimental Brain Research 1993, 96(3):457-472.
15. Giraldo E., Micheletti R., Montagna E., Giachetti A., Vigano M.A., Ladinsky H., et al. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. Journal of Pharmacology and Experimental Therapeutics 1988, 244(3):1016-1020.
16. Griffiths S., Scott H., Glover C., Bienemann A., Ghorbel M.T., Uney J., et al. Expression of long-term depression underlies visual recognition memory. Neuron 2008, 58(2):186-194. 10.1016/j.neuron.2008.02.022.
17. Gulledge A.T., Kawaguchi Y. Phasic cholinergic signaling in the hippocampus: functional homology with the neocortex?. Hippocampus 2007, 17(5):327-332. 10.1002/hipo.20279.
18. Hammer R., Berrie C.P., Birdsall N.J., Burgen A.S., Hulme E.C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 1980, 283(5742):90-92.
19. Hasselmo M.E., Stern C.E. Mechanisms underlying working memory for novel information. Trends in Cognitive Sciences 2006, 10(11):487-493. 10.1016/j.tics.2006.09.005.
20. Ishii M., Kurachi Y. Muscarinic acetylcholine receptors. Current Pharmaceutical Design 2006, 12(28):3573-3581.
21. Kirkwood A., Rozas C., Kirkwood J., Perez F., Bear M.F. Modulation of long-term synaptic depression in visual cortex by acetylcholine and norepinephrine. Journal of Neuroscience 1999, 19(5):1599-1609.
22. Lachowicz J.E., Duffy R.A., Ruperto V., Kozlowski J., Zhou G., Clader J., et al. Facilitation of acetylcholine release and improvement in cognition by a selective M2 muscarinic antagonist, SCH 72788. Life Sciences 2001, 68(22-23):2585-2592.
23. Lanzafame A.A., Christopoulos A., Mitchelson F. Cellular signaling mechanisms for muscarinic acetylcholine receptors. Receptors and Channels 2003, 9(4):241-260.
24. Lazareno S., Roberts F.F. Functional and binding studies with muscarinic M2-subtype selective antagonists. British Journal of Pharmacology 1989, 98(1):309-317.
25. Levey A.I. Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. Proceedings of the National Academy of Science USA 1996, 93(24):13541-13546.
26. Lucas-Meunier E., Fossier P., Baux G., Amar M. Cholinergic modulation of the cortical neuronal network. Pflugers Archiv. European Journal of Physiology 2003, 446(1):17-29. 10.1007/s00424-002-0999-2.
27. Marino M.J., Rouse S.T., Levey A.I., Potter L.T., Conn P.J. Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proceedings of the National Academy of Science USA 1998, 95(19):11465-11470.
28. Marrion N.V. Control of M-current. Annual Review of Physiology 1997, 59:483-504. 10.1146/annurev.physiol.59.1.483.
29. Massey P.V., Bhabra G., Cho K., Brown M.W., Bashir Z.I. Activation of muscarinic receptors induces protein synthesis-dependent long-lasting depression in the perirhinal cortex. European Journal of Neuroscience 2001, 14(1):145-152.
30. McCoy P.A., McMahon L.L. Muscarinic receptor dependent long-term depression in rat visual cortex is PKC independent but requires ERK1/2 activation and protein synthesis. Journal of Neurophysiology 2007, 98(4):1862-1870. 10.1152/jn.00510.2007.
31. Naor C., Dudai Y. Transient impairment of cholinergic function in the rat insular cortex disrupts the encoding of taste in conditioned taste aversion. Behavioural Brain Research 1996, 79(1-2):61-67.
32. Navaroli V.L., Zhao Y., Boguszewski P., Brown T.H. Muscarinic receptor activation enables persistent firing in pyramidal neurons from superficial layers of dorsal perirhinal cortex. Hippocampus 2011, 10.1002/hipo.20975.
33. Ohno M., Yamamoto T., Watanabe S. Blockade of hippocampal m1 muscarinic receptors impairs working memory performance of rats. Brain Research 1994, 650(2):260-266.
34. Ohnuki T., Nomura Y. Effects of selective muscarinic antagonists, pirenzepine and AF-DX 116, on passive avoidance tasks in mice. Biological & Pharmaceutical Bulletin 1996, 19(6):814-818.
35. Packard M.G., Regenold W., Quirion R., White N.M. Post-training injection of the acetylcholine M2 receptor antagonist AF-DX 116 improves memory. Brain Research 1990, 524(1):72-76.
36. Ramirez-Lugo L., Miranda M.I., Escobar M.L., Espinosa E., Bermudez-Rattoni F. The role of cortical cholinergic pre- and post-synaptic receptors in taste memory formation. Neurobiology of Learning and Memory 2003, 79(2):184-193.
37. Rouse S.T., Marino M.J., Potter L.T., Conn P.J., Levey A.I. Muscarinic receptor subtypes involved in hippocampal circuits. Life Sciences 1999, 64(6-7):501-509.
38. Rowe W.B., O'Donnell J.P., Pearson D., Rose G.M., Meaney M.J., Quirion R. Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats. Behavioural Brain Research 2003, 145(1-2):171-178.
39. Saunders R.C., Aigner T.G., Frank J.A. Magnetic resonance imaging of the rhesus monkey brain: use for stereotactic neurosurgery. Experimental Brain Research 1990, 81(2):443-446.
40. Scheiderer C.L., Smith C.C., McCutchen E., McCoy P.A., Thacker E.E., Kolasa K., et al. Coactivation of M(1) muscarinic and alpha1 adrenergic receptors stimulates extracellular signal-regulated protein kinase and induces long-term depression at CA3-CA1 synapses in rat hippocampus. Journal of Neuroscience 2008, 28(20):5350-5358. 10.1523/JNEUROSCI.5058-06.2008.
41. Schon K., Atri A., Hasselmo M.E., Tricarico M.D., LoPresti M.L., Stern C.E. Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans. Journal of Neuroscience 2005, 25(40):9112-9123. 10.1523/JNEUROSCI.1982-05.2005.
42. Schon K., Hasselmo M.E., Lopresti M.L., Tricarico M.D., Stern C.E. Persistence of parahippocampal representation in the absence of stimulus input enhances long-term encoding: a functional magnetic resonance imaging study of subsequent memory after a delayed match-to-sample task. Journal of Neuroscience 2004, 24(49):11088-11097. 10.1523/JNEUROSCI.3807-04.2004.
43. Smiley J.F., Levey A.I., Mesulam M.M. M2 muscarinic receptor immunolocalization in cholinergic cells of the monkey basal forebrain and striatum. Neuroscience 1999, 90(3):803-814.
44. Tang Y., Mishkin M., Aigner T.G. Effects of muscarinic blockade in perirhinal cortex during visual recognition. Proceedings of the National Academy of Science USA 1997, 94(23):12667-12669.
45. Tinsley C.J., Fontaine-Palmer N.S., Vincent M., Endean E.P., Aggleton J.P., Brown M.W., et al. Differing time dependencies of object recognition memory impairments produced by nicotinic and muscarinic cholinergic antagonism in perirhinal cortex. Learning & Memory 2011, 18(7):484-492. 10.1101/lm.2274911.
46. Vannucchi M.G., Pepeu G. Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus. Neuroscience Letters 1995, 190(1):53-56.
47. Vilaro M.T., Wiederhold K.H., Palacios J.M., Mengod G. Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience 1992, 47(2):367-393.
48. Warburton E.C., Koder T., Cho K., Massey P.V., Duguid G., Barker G.R., et al. Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory. Neuron 2003, 38(6):987-996.
49. Wess J. Molecular biology of muscarinic acetylcholine receptors. Critical Reviews in Neurobiology 1996, 10(1):69-99.
50. Xiang J.Z., Brown M.W. Differential neuronal encoding of novelty, familiarity and recency in regions of the anterior temporal lobe. Neuropharmacology 1998, 37(4-5):657-676.
51. Yan H.D., Villalobos C., Andrade R. TRPC channels mediate a muscarinic receptor-induced afterdepolarization in cerebral cortex. Journal of Neuroscience 2009, 29(32):10038-10046. 10.1523/JNEUROSCI.1042-09.2009.
52. Zhu X.O., Brown M.W., McCabe B.J., Aggleton J.P. Effects of the novelty or familiarity of visual stimuli on the expression of the immediate early gene c-fos in rat brain. Neuroscience 1995, 69(3):821-829. http://dx.doi.org/0306-4522(95)00320-I.
53. Zhu X.O., McCabe B.J., Aggleton J.P., Brown M.W. Mapping visual recognition memory through expression of the immediate early gene c-fos. Neuroreport 1996, 7(11):1871-1875.